JAMA Oncology —The Year in Review, 2017

This has been a terrific year for JAMA Oncology. Our debut impact factor of 16.56 placed us as one of the highest-ranking oncology journals. JAMA Oncology published 30 of the top 50 papers among oncology journals as measured by Altmetric. We would like to thank our authors, reviewers, and readers for the significant contributions made to the journal this past year. The editorial board and I are honored to have the opportunity to serve the oncology community by offering original, innovative, and timely scientific content that has a direct impact on researchers, clinicians, and the patients we serve.

http://ift.tt/2Fz6fYn